125 related articles for article (PubMed ID: 28106540)
1. Detection of human breast cancer cells using a 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles.
Shan XH; Wang P; Xiong F; Lu HY; Hu H
Cancer Biomark; 2017; 18(4):367-374. PubMed ID: 28106540
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the targeting properties of 2-deoxy-D-glucose-conjugated nanoparticles to breast cancer MDA-MB-231 cells and breast fibroblasts cells].
Wang P; Shan XH; Xiong F; Gu N; Qian H; Fan Y; Wang YF
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):566-71. PubMed ID: 24314212
[TBL] [Abstract][Full Text] [Related]
3. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
4. MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles.
Shan XH; Wang P; Xiong F; Gu N; Hu H; Qian W; Lu HY; Fan Y
Mol Imaging Biol; 2016 Feb; 18(1):24-33. PubMed ID: 26150194
[TBL] [Abstract][Full Text] [Related]
5. Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-D-g1ucose modified SPIOs.
Shan XH; Hu H; Xiong F; Gu N; Geng XD; Zhu W; Lin J; Wang YF
Eur J Radiol; 2012 Jan; 81(1):95-9. PubMed ID: 21440393
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization of 2-deoxy-D-glucose functionalized dimercaptosuccinic acid-coated maghemite nanoparticles for targeting tumor cells.
Xiong F; Zhu ZY; Xiong C; Hua XQ; Shan XH; Zhang Y; Gu N
Pharm Res; 2012 Apr; 29(4):1087-97. PubMed ID: 22173782
[TBL] [Abstract][Full Text] [Related]
7. Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
Silva LH; da Silva JR; Ferreira GA; Silva RC; Lima EC; Azevedo RB; Oliveira DM
J Nanobiotechnology; 2016 Jul; 14(1):59. PubMed ID: 27431051
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Diagnosed by MRI Using Mesoporous TiO₂-Coated (Fe₃O₄) Nanoparticles.
Zheng B; Xue M; Zhang X; Tian N; Wang D
J Nanosci Nanotechnol; 2020 Oct; 20(10):6561-6567. PubMed ID: 32385014
[No Abstract] [Full Text] [Related]
9. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
10. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
Calero M; Chiappi M; Lazaro-Carrillo A; Rodríguez MJ; Chichón FJ; Crosbie-Staunton K; Prina-Mello A; Volkov Y; Villanueva A; Carrascosa JL
J Nanobiotechnology; 2015 Feb; 13():16. PubMed ID: 25880445
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-D-Glucose Modified Magnetic Nanoparticles with Dual Functional Properties: Nanothermotherapy and Magnetic Resonance Imaging.
Zhao L; Zheng Y; Yan H; Xie W; Sun X; Li N; Tang J
J Nanosci Nanotechnol; 2016 Mar; 16(3):2401-7. PubMed ID: 27455648
[TBL] [Abstract][Full Text] [Related]
12. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
[TBL] [Abstract][Full Text] [Related]
14. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide.
Mou Y; Hou Y; Chen B; Hua Z; Zhang Y; Xie H; Xia G; Wang Z; Huang X; Han W; Ni Y; Hu Q
Int J Nanomedicine; 2011; 6():2633-40. PubMed ID: 22114494
[TBL] [Abstract][Full Text] [Related]
15. 2, 3-dimercaptosuccinic acid-modified iron oxide clusters for magnetic resonance imaging.
Xiong F; Yan C; Tian J; Geng K; Zhu Z; Song L; Zhang Y; Mulvale M; Gu N
J Pharm Sci; 2014 Dec; 103(12):4030-4037. PubMed ID: 25335461
[TBL] [Abstract][Full Text] [Related]
16. Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies.
Danhier P; Deumer G; Joudiou N; Bouzin C; Levêque P; Haufroid V; Jordan BF; Feron O; Sonveaux P; Gallez B
Oncotarget; 2017 Jun; 8(24):38876-38885. PubMed ID: 28467814
[TBL] [Abstract][Full Text] [Related]
17. Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis.
Zhang X; Kong F; Wang T; Huang X; Li W; Zhang M; Wen T; Liu J; Zhang Y; Meng J; Xu H
Nanotoxicology; 2022; 16(9-10):829-843. PubMed ID: 36660964
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
[TBL] [Abstract][Full Text] [Related]
19. A value-added exopolysaccharide as a coating agent for MRI nanoprobes.
Palma SI; Rodrigues CA; Carvalho A; Morales Mdel P; Freitas F; Fernandes AR; Cabral JM; Roque AC
Nanoscale; 2015 Sep; 7(34):14272-83. PubMed ID: 26186402
[TBL] [Abstract][Full Text] [Related]
20. DMSA-coated cubic iron oxide nanoparticles as potential therapeutic agents.
Çitoğlu S; Coşkun ÖD; Tung LD; Onur MA; Thanh NTK
Nanomedicine (Lond); 2021 May; 16(11):925-941. PubMed ID: 34015971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
